GESA Infection Control in Endoscopy Consensus Statement on Carbapenemase-Producing Enterobacteriaceae (CPE)

Benedict Devereaux 1, Rajvinder Singh 1, Di Jones 2 Robyn Brown 2, Eugene Athan 3, Sue Greig 4

1 GESA
2 GENCA
3 ASID
4 ACICP

 

Since the 2010 publication of GESA’s Infection Control in Endoscopy Guidelines, there have been several overseas outbreaks of carbapenemase-producing Enterobacteriaceae (CPE) linked to the use of flexible endoscopes. In response to these outbreaks, the Board of the Gastroenterological Society of Australia (GESA) appointed a multi-organisation expert committee to develop consensus statements addressing this issue. The committee comprises representatives from GESA, the Gastroenterological Nurses College of Australia (GENCA), the Australasian College for Infection Prevention and Control (ACIPC) and the Australasian Society for Infectious Diseases (ASID). The committee examined and assessed the published literature and using the Delphi methodology produced the following consensus statements, which in their expert opinion are considered best practice. Many of the recommendations in the statements reflect procedures and policies already widely practised in endoscopy units around Australia

Aim: to ensure the highest possible standards in flexible endoscope reprocessing thereby optimising patient safety. To further raise the standard of endoscopic reprocessing in Australia to reduce the risk of CPE transmission. The consensus statements: Offer specific guidance in addition to the Infection Control in Endoscopy guidelines Multi-society assessment, Considered and evidence based, Preventative and Specific to CPE. Future potential to extrapolate to other MDRO’s.